News

We recently published a list of Billionaire Andreas Halvorsen’s 10 Stock Picks With Huge Upside Potential. In this article, ...
We recently published a list of 11 Best Guru Stocks to Buy According to Wall Street Analysts. In this article, we are going ...
In this article, we are going to take a look at where NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) stands against other Guru stocks to invest in. Wall Street seems to be breathing a little ...
where the knitwear brand holds its showroom each season – guests are invited to stay for food and drink served on crockery shipped from Amsterdam – as well as at its various pop-ups in St Moritz, Los ...
Pharmaceutical company Eli Lilly announced promising clinical trial results this week for a daily pill to treat obesity and diabetes. Besides the good news of minimal side effects and impressive ...
In early March 2024, the Food and Drug Administration (FDA) cleared TME Pharma’s Investigational New Drug (IND) application on the basis of the protocol for its upcoming randomized Phase 2 trial ...
First-in-class therapeutic, N17350, demonstrates potent and selective tumor killing in chemotherapy-naïve and chemotherapy-treated ovarian cancer patient-derived models Onchilles Pharma ...
Minnesota Timberwolves rookie Rob Dillingham is already making waves off the court, as his new RD4 logo and growing presence in the Nike basketball lineup are gaining widespread attention. Ahead ...
UroGen Pharma (URGN) highlights a duration of response ... irrespective of whether their cancer was new-onset or recurrent. Of these patients, 21 had new-onset UTUC, and 20 had recurrent UTUC ...
H.C. Wainwright lowered the firm’s price target on Innate Pharma (IPHA) to $11 from $11.50 and keeps a Buy rating on the shares. The firm postponed the U.S. launch of IPH6101 to 2029 from ...